October 9, 2023 October 9, 2023Categories New TrialsNow Enrolling: The EAQ211 trial is evaluating the impact of social and genetic factors on outcomes in teen and young adult cancer survivorsThrough a series of simple blood tests and patient questionnaires, researchers are studying the effects of trauma and other adverse life experiences on young cancer survivors
July 19, 2023 July 19, 2023Categories New TrialsNow Enrolling: The DIRECT study is testing how well FDG-PET/CT imaging can predict if treatment is working prior to surgery for patients with HER2-positive breast cancerThis study is for patients who have untreated, early-stage HER2-positive breast cancer
July 19, 2023 July 19, 2023Categories New TrialsNow Enrolling: ComboMATCH treatment trial E4 is testing a new option for patients with advanced solid tumors that progress despite taxane chemotherapyThis study is for patients with solid tumors that are progressing after treatment with taxane therapies
March 23, 2023 March 23, 2023Categories New TrialsThe ComboMATCH precision medicine initiative is getting set to evaluate several new anti-cancer drug combinationsHospitals and cancer centers nationwide are opening ComboMATCH on a rolling basis over the next few months